VENLAFAXINE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	RACEMIC
Molecular Formula	C17H27NO2
Molecular Weight	277.4018
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of VENLAFAXINE

Structure Search

SMILES

COC1=CC=C(C=C1)C(CN(C)C)C2(O)CCCCC2

InChI

InChIKey=PNVNVHUZROJLTJ-UHFFFAOYSA-N

InChI=1S/C17H27NO2/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14/h7-10,16,19H,4-6,11-13H2,1-3H3

HIDE SMILES / InChI

Molecular Formula	C17H27NO2
Molecular Weight	277.4018
Charge	0
Count

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 15:56:35 UTC 2023` Edited by `admin` on `Fri Dec 15 15:56:35 UTC 2023`
Record UNII	GRZ5RCB1QG
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

VENLAFAXINE

Official Name

English

VENLOR

Common Name

English

CYCLOHEXANOL, 1-(2-(DIMETHYLAMINO)-1-(4-METHOXYPHENYL)ETHYL)-

Systematic Name

English

VENLAFAXINE [VANDF]

Common Name

English

venlafaxine [INN]

Common Name

English

NSC-758676

Code

English

TREVILOR

Common Name

English

EFECTIN

Brand Name

English

Venlafaxine [WHO-DD]

Common Name

English

(±)-1-(.ALPHA.-((DIMETHYLAMINO)METHYL)-P-METHOXYBENZYL)CYCLOHEXANOL

Common Name

English

VENLAFAXINE [MI]

Common Name

English

KANGHONG

Common Name

English

VELAFAX

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C265

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

WHO-ATC

N06AX16

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

NDF-RT

N0000000102

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

WHO-VATC

QN06AX16

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

NDF-RT

N0000000109

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

LIVERTOX

NBK548799

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

NDF-RT

N0000175749

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

Code System Code Type Description

EVMPD

SUB00034MIG

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

PRIMARY

CAS

93413-69-5

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

PRIMARY

ChEMBL

CHEMBL637

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

PRIMARY

NSC

758676

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

PRIMARY

FDA UNII

GRZ5RCB1QG

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

PRIMARY

CHEBI

9943

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

PRIMARY

SMS_ID

100000092624

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

PRIMARY

DRUG CENTRAL

2813

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

PRIMARY

NCI_THESAURUS

C1278

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

PRIMARY

DAILYMED

GRZ5RCB1QG

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

PRIMARY

LACTMED

Venlafaxine

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

PRIMARY

WIKIPEDIA

VENLAFAXINE

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

PRIMARY

INN

6358

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

PRIMARY

MESH

C047426

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

PRIMARY

HSDB

6699

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

PRIMARY

IUPHAR

7321

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

PRIMARY

MERCK INDEX

m11410

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

PRIMARY

Merck Index

RXCUI

39786

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

PRIMARY

RxNorm

DRUG BANK

DB00285

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

PRIMARY

EPA CompTox

DTXSID6023737

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

PRIMARY

PUBCHEM

5656

Created by admin on Fri Dec 15 15:56:35 UTC 2023 , Edited by admin on Fri Dec 15 15:56:35 UTC 2023

PRIMARY

Related Record Type Details


					CJZ26L1EGI

SODIUM-DEPENDENT SEROTONIN TRANSPORTER

TARGET -> INHIBITOR

Qualification:

IC50

Amount:


					1R8EN4W1EG

VENLAFAXINE BESYLATE

SALT/SOLVATE -> PARENT

Amount:


					6D53G0FD0Z

PLASMA PROTEIN FRACTION (HUMAN)

BINDER->LIGAND

Amount:


					18XP3YT5NH

VENLAFAXINE BESYLATE MONOHYDRATE

SALT/SOLVATE -> PARENT

Amount:


					HN86OLH1NW

SODIUM-DEPENDENT NORADRENALINE TRANSPORTER

TARGET -> INHIBITOR

Amount:


					7D7RX5A8MO

VENLAFAXINE HYDROCHLORIDE

SALT/SOLVATE -> PARENT

Amount:


					B33212715Z

VENLAFAXINE, (R)-

ENANTIOMER -> RACEMATE

Amount:


					5FIM3PQD9S

VENLAFAXINE, (S)-

ENANTIOMER -> RACEMATE

Amount:

Related Record Type Details


					1H23L3816Q

N,O-DIDESMETHYLVENLAFAXINE-GLUCURONIDE

METABOLITE INACTIVE -> PARENT

Comments:

Unit: percent of dose in urine

Interaction Type:

IN-VIVO

Qualification:

URINE

Amount:


					NG99554ANW

METABOLITE ACTIVE -> PARENT

Interaction Type:

MAJOR

Amount:


					68PDXVEFMN

DESVENLAFAXINE-O-GLUCURONIDE

METABOLITE INACTIVE -> PARENT

Comments:

Unit: percent of dose in urine

Interaction Type:

IN-VIVO

Qualification:

URINE

Amount:


					L00G2AX0BL

TRIDESMETHYLVENLAFAXINE

METABOLITE INACTIVE -> PARENT

Comments:

Unit: percent of dose in urine

Interaction Type:

IN-VIVO

Qualification:

URINE

Amount:


					DYW3W9739Y

N,O-DIDESMETHYLVENLAFAXINE

METABOLITE INACTIVE -> PARENT

Interaction Type:

MINOR

Amount:

Related Record Type Details


					ZB22ENF0XR

DESVENLAFAXINE SUCCINATE

PARENT -> IMPURITY

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

USP

Amount:


					NG99554ANW

PARENT -> IMPURITY

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

USP

Amount:

Related Record Type Details


					GRZ5RCB1QG

ACTIVE MOIETY

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Route of Elimination	PHARMACOKINETIC				EXCRETED UNCHANGED: 5%

Route of Elimination	PHARMACOKINETIC

Volume of Distribution	PHARMACOKINETIC

PROTEIN BINDING	PHARMACOKINETIC

ORAL BIOAVAILABILITY	PHARMACOKINETIC				EXTENDED-RELEASE CAPSULE

MAXIMUM TOLERATED DOSE	TOXICITY				IMMEDIATE-RELEASE TABLET: 375 MG/DAY

Biological Half-life	PHARMACOKINETIC				RENAL IMPAIRMENT: PROLONGED BY ABOUT 50% O-DESMETHYLVENLAFAXINE, HEPATIC CIRRHOSIS: PROLONGED BY ABOUT 60% O-DESMETHYLVENLAFAXINE: 11 HOURS HEPATIC CIRRHOSIS: PROLONGED BY ABOUT 30% O-DESMETHYLVENLAFAXINE, DIALYSIS: PROLONGED BY ABOUT 142% DIALYSIS: PROLONGED BY ABOUT 180% O-DESMETHYLVENLAFAXINE, RENAL IMPAIRMENT: PROLONGED BY ABOUT 40%